Progress in immunotherapy for brain metastatic melanoma

Shicheng Zheng, Zhongqiao Lin, Ruibo Zhang, Zihang Cheng, Kaixin Li, Chenkai Gu, Yu Chen, Jing Lin · 2025

Read Progress in immunotherapy for brain metastatic melanoma by Shicheng Zheng, Zhongqiao Lin, Ruibo Zhang, Zihang Cheng, Kaixin Li, Chenkai Gu, Yu Chen, Jing Lin (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11810730.txt.

Description

Melanoma that reaches the brain was once a death sentence measured in weeks, and immune therapy has rewritten that outlook unevenly. Shicheng Zheng and seven co-authors review the progress in this 2024 paper. Checkpoint drugs that release the immune system's brakes lead the field, and combinations multiply the options: two checkpoints together, or one paired with chemotherapy, targeted drugs, or radiation.

The brain is a hard theater: barriers keep drugs out, and tumors hide in tissue the immune system patrols lightly. Trials keep reporting which pairings crack that protection and for whom. The authors also weigh the obstacles that remain, from resistance to side effects, and point to where research and clinic should push next. The review serves doctors choosing among fast-multiplying regimens for a feared complication.

Catalog record

CREATORShicheng Zheng, Zhongqiao Lin, Ruibo Zhang, Zihang Cheng, Kaixin Li, Chenkai Gu, Yu Chen, Jing Lin
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11810730

Browse the full library · About the Tower of Babel